Found 751 matching trials
A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis
PHASE2The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)
N/ADevelop a Metastatic Breast Cancer (MBC)-specific electronic Treatment Plan...
Location
University of Alabama at Birmingham
OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time
NAMonotherapy with a P2Y12 inhibitor after a minimum period of DAPT following...
Location
General Hospital of Northern Theater Command
TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI
PHASE4This study evaluates the efficacy and safety of tailored antithrombotic the...
Location
Hallym University Sacred Heart Hospital
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
PHASE1RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
PHASE1RATIONALE: Recombinant human mannose-binding lectin (MBL) may be effective ...
Location
Children's Hospital of Orange County
Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)
N/AProspective, multicenter, non-interventional study conducted over 6 months,...
Safety and Immunogenicity in Age De-Escalation of PfSPZ Vaccine in Tanzanian Adults, Children, and Infants
PHASE1The present trial will evaluate safety and tolerability as well as the vacc...
Location
Bagamoyo Research and Training center of the Ifakara Health Institute
ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer
NAThis study aims to evaluate the clinical feasibility of first-line immunoch...
Location
The Obstetrics and Gynecology Hospital of Fudan University
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
PHASE1This study is a Phase I/II, multicenter, first-in-human, open-label dose-es...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute at HealthONE